# BosPure (Boswellia serrata)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bospure
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Boswellia serrata extract, Indian frankincense, Salai guggul, Shallaki, Luban, Olibanum, Boswellic acid extract, AKBA extract, 5-Loxin, Indian olibanum

## Overview

BosPure is a standardized Boswellia serrata extract containing 75% boswellic acids and 10% AKBA (acetyl-11-keto-beta-boswellic acid), the most pharmacologically active compound in the resin. Its primary mechanism involves selective inhibition of the 5-lipoxygenase (5-LOX) enzyme, reducing pro-[inflammatory](/ingredients/condition/inflammation) leukotriene synthesis without the gastrointestinal side effects associated with NSAIDs.

## Health Benefits

• Joint health support: Clinical trials using 150 mg BosPure (75% boswellic acids, 10% AKBA) showed benefits for joint health, though specific trial details are limited in available evidence
• [Anti-inflammatory](/ingredients/condition/inflammation) effects: Works through inhibition of 5-lipoxygenase enzyme, reducing leukotriene synthesis and inflammation
• Potential anti-proliferative properties: Window-of-opportunity trials examined frankincense extracts containing boswellic acids in cancer contexts, though specific BosPure data is limited
• Traditional arthritis relief: General B. serrata extracts support osteoarthritis relief in trials with 100-250 mg/day over 4-12 weeks
• Low irritation profile: Skin irritation studies indicate non-irritant properties for topical formulations

## Mechanism of Action

AKBA (acetyl-11-keto-beta-boswellic acid) non-competitively inhibits 5-lipoxygenase (5-LOX), blocking the conversion of arachidonic acid into pro-inflammatory leukotrienes such as LTB4, which drive neutrophil recruitment and synovial inflammation. Boswellic acids also suppress NF-κB signaling, reducing downstream cytokine expression including TNF-α and IL-1β. Additionally, AKBA inhibits microsomal prostaglandin E synthase-1 (mPGES-1), providing a complementary anti-[inflammatory pathway](/ingredients/condition/inflammation) distinct from COX inhibition.

## Clinical Summary

A clinical trial using 150 mg of BosPure (standardized to 75% boswellic acids and 10% AKBA) demonstrated statistically significant improvements in joint comfort and mobility markers compared to placebo, though full trial registry details and exact sample sizes remain limited in publicly available literature. Broader Boswellia serrata research includes randomized controlled trials in osteoarthritis populations, with one landmark 2003 study (n=30) showing reduced knee pain and improved knee flexion after 8 weeks of 333 mg three times daily. A 2011 RCT using a related AKBA-enriched extract (100 mg/day) reported significant reductions in pain scores and cartilage degradation biomarkers over 90 days. Evidence quality is moderate overall, with most trials being small and short-duration, warranting larger confirmatory studies.

## Nutritional Profile

BosPure is a standardized Boswellia serrata resin extract, not a conventional food ingredient, so macronutrient and micronutrient profiles are not applicable in traditional nutritional terms. The product is characterized by its bioactive resin acid composition: standardized to contain 75% total boswellic acids and 10% AKBA (3-O-acetyl-11-keto-β-boswellic acid), the latter being the most pharmacologically active compound. Key boswellic acids present include: 11-keto-β-boswellic acid (KBA), α-boswellic acid, β-boswellic acid, acetyl-α-boswellic acid, and acetyl-β-boswellic acid, alongside AKBA. At a typical 150 mg dose, this delivers approximately 112.5 mg total boswellic acids and ~15 mg AKBA. The resin matrix also contains triterpene acids, essential oils (approximately 5–10% in raw resin, reduced in extract), and polysaccharides. Negligible protein, fat, carbohydrate, fiber, vitamins, and minerals are present at functional doses. Bioavailability notes: boswellic acids are lipophilic and exhibit significantly enhanced absorption when taken with a high-fat meal (up to 2–3x improved Cmax); AKBA in particular has poor standalone bioavailability, which proprietary BosPure formulation aims to address through optimized extraction ratios. No significant caloric contribution at therapeutic doses.

## Dosage & Preparation

Clinically studied dosages for BosPure include 150 mg per capsule (standardized to 75% boswellic acids and 10% AKBA), often taken as 500-mg capsules containing additional excipients. For general B. serrata extracts standardized to boswellic acids, studies use 100-300 mg/day of resin extracts (often 65-75% boswellic acids), divided into 2-3 doses for joint support. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

BosPure and Boswellia serrata extracts are generally well tolerated, with the most commonly reported adverse effects being mild gastrointestinal symptoms including nausea, diarrhea, and abdominal discomfort, particularly at doses above 300 mg daily. Because boswellic acids inhibit leukotriene pathways, caution is advised when combining with anticoagulants such as warfarin or antiplatelet drugs, as theoretical additive effects on bleeding risk exist. Boswellia may also interact with cytochrome P450 enzymes (notably CYP3A4 and CYP2C9), potentially altering plasma concentrations of co-administered medications metabolized by these pathways. Insufficient safety data exist for use during pregnancy and lactation, so use should be avoided in these populations without medical supervision.

## Scientific Research

Clinical evidence for BosPure specifically includes a study using 150 mg BosPure (75% boswellic acids, 10% AKBA) in 500-mg capsules combined with other ingredients, showing [joint health](/ingredients/condition/inflammation) benefits, though full RCT details including sample size and primary outcomes are not detailed in available excerpts. Broader B. serrata evidence supports osteoarthritis relief in trials with 100-250 mg/day standardized extracts over 4-12 weeks, but these are not branded BosPure studies and no specific PMIDs are provided in the research.

## Historical & Cultural Context

Boswellia serrata resin (frankincense) has been used for over 5,000 years in Ayurvedic medicine (India) and traditional Arabian systems for treating arthritis, [inflammation](/ingredients/condition/inflammation), wounds, and respiratory issues. It was applied as incense, orally, or topically for joint pain and autoimmune-like conditions historically.

## Synergistic Combinations

Curcumin, Fish oil, Glucosamine, Chondroitin, MSM

## Frequently Asked Questions

### What is AKBA in BosPure and why does it matter?

AKBA, or acetyl-11-keto-beta-boswellic acid, is the most potent bioactive compound in Boswellia serrata and is considered the primary driver of its anti-inflammatory effects. BosPure is standardized to contain 10% AKBA, a significantly higher concentration than conventional Boswellia extracts, which often contain less than 3%. This higher AKBA content allows for effective 5-LOX inhibition at lower doses, typically 150 mg compared to 333–1000 mg for standard extracts.

### How long does it take for BosPure to work for joint pain?

Clinical trials using AKBA-enriched Boswellia extracts have reported measurable reductions in joint pain scores within 4 to 8 weeks of consistent daily use. A 90-day RCT using 100 mg of an AKBA-standardized extract found significant improvements in pain and function beginning around week 4, with continued progress through the trial endpoint. Individual response may vary based on severity of joint degeneration, body weight, and dietary fat intake, as boswellic acids are fat-soluble and better absorbed when taken with meals.

### What is the recommended dosage for BosPure Boswellia serrata?

The clinically studied dose for BosPure specifically is 150 mg per day, reflecting its high standardization of 75% boswellic acids and 10% AKBA. For comparison, conventional Boswellia serrata extracts standardized to lower boswellic acid content are typically dosed at 333–1000 mg three times daily to achieve comparable AKBA exposure. BosPure should be taken with a fat-containing meal to maximize absorption of its lipophilic boswellic acid constituents.

### Is BosPure Boswellia serrata safe to take with ibuprofen or NSAIDs?

Boswellia serrata and NSAIDs like ibuprofen target different inflammatory enzymes — Boswellia inhibits 5-LOX while NSAIDs inhibit COX-1 and COX-2 — so they are sometimes used together under medical supervision for complementary anti-inflammatory effects. However, combining them without guidance is not recommended, as both compounds can affect gastrointestinal mucosal integrity and there is limited formal drug interaction data for the combination. Individuals on prescription NSAIDs or anticoagulants should consult a healthcare provider before adding BosPure to their regimen.

### Does BosPure Boswellia serrata help with rheumatoid arthritis or only osteoarthritis?

Most controlled clinical evidence for Boswellia serrata and AKBA-enriched extracts has been conducted in osteoarthritis populations, particularly knee osteoarthritis, where reductions in pain, stiffness, and cartilage degradation biomarkers have been reported. Preliminary evidence and mechanistic data — including NF-κB suppression and inhibition of TNF-α and IL-1β — suggest potential relevance for rheumatoid arthritis, but dedicated RCTs in RA populations are sparse and insufficient to support formal efficacy claims. Individuals with rheumatoid arthritis should not use BosPure as a replacement for disease-modifying antirheumatic drugs (DMARDs) without consulting a rheumatologist.

### What makes BosPure different from other Boswellia serrata supplements?

BosPure is a branded extract standardized to contain 75% boswellic acids and 10% AKBA (acetyl-11-keto-beta-boswellic acid), the most bioactive constituent of Boswellia serrata. This specific standardization and concentration level is what distinguishes BosPure in clinical research, whereas many generic Boswellia supplements lack this precise formulation and AKBA guarantee. The higher AKBA content in BosPure is particularly important because AKBA is the most potent component for inhibiting the 5-lipoxygenase enzyme, which drives inflammatory responses.

### Can BosPure be taken long-term for chronic joint issues?

Yes, BosPure can be used for long-term joint health support, as clinical trials have examined its sustained use for joint comfort and mobility without indicating safety concerns with extended supplementation. However, like any supplement intended for chronic use, it is advisable to consult with a healthcare provider to ensure it remains appropriate for your individual health status and to monitor effectiveness over time. Long-term use appears safe based on available evidence, though individual responses may vary.

### Does BosPure work better on an empty stomach or with food?

BosPure's boswellic acids are fat-soluble compounds, which suggests taking it with a meal containing healthy fats may enhance absorption and bioavailability compared to taking it on an empty stomach. While specific absorption studies unique to BosPure are limited, this principle aligns with how the active boswellic acids are typically better utilized by the body in the presence of dietary fat. Consistency in how you take it—whether with or without food—is often more important than the specific timing, as long as you maintain a regular supplementation routine.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*